Clinical Trials Sponsored by Shanghai Jiatan Pharmatech Co., Ltd

Total 1276 results

Shanghai Haiyan Pharmaceutical Technology Co.,...

Recruiting

A Phase 1 Study of YZJ-5053 Tablets in Participants With Advanced Solid Tumors

Solid Tumor

China
Shanghai Runshi Pharmaceutical Technology Co., Ltd

Not yet recruiting

A Study of Simmitinib Plus SG001 in Advanced Solid Tumors

Advanced Solid Tumor

China
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.

Recruiting

An Open-Label Study of Aficamten for Chinese Patients With Symptomatic oHCM

Obstructive Hypertrophic Cardiomyopathy

China
Shanghai Ming Ju Biotechnology Co., Ltd.

Not yet recruiting

Relmacabtagene Autoleucel as Second-Line Therapy in Adult Patients With Aggressive B-cell NHL

Lymphoma, Large B-Cell, Diffuse | High-grade B-cell Lymphoma | Follicular Lymphoma Grade 3B | Mediastinal B-Cell Diffuse Large Cell Lymphoma

China
Shanghai Bomaian Medical Technology Co., Ltd

Not yet recruiting

Rapamycin Coated Balloon Dilation Catheter for Arteriovenous Fistula

Peripheral Arterial Disease
Asia Cell Therapeutics (Shanghai) Co., Ltd.

Not yet recruiting

Safety of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in Patients With Decompensated Hepatitis B Cirrhosis

Decompensated Liver Cirrhosis
Bio Genuine (Shanghai) Biotech Co., Ltd.

Recruiting

Efficacy and Safety of BG2109 in Chinese Subjects With Endometriosis

Endometriosis | Moderate to Severe Endometriosis-associated Pain

China
argenx
Zai Lab (Shanghai) Co., Ltd.

Recruiting

A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients With Lupus Nephritis (ZL-1103-013)

Lupus Nephritis

China
Shanghai Huihe Medical Technology Co., Ltd

Not yet recruiting

A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Efficacy and Safety of the Transcatheter Tricuspid Valvuloplasty System in Patients With Severe or Above Tricuspid Regurgitation

Tricuspid Regurgitation
Shanghai Ming Ju Biotechnology Co., Ltd.

Recruiting

CD19-CART(Relma-cel) for Moderate to Severe Active Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

China
Shanghai Bomaian Medical Technology Co., Ltd

Not yet recruiting

To Verify the Efficacy and Safety of Rapamycin Coated Peripheral Balloon Catheter in the Treatment of Femoral Popliteal Artery Disease

Peripheral Arterial Disease

China
Shanghai Haiyan Pharmaceutical Technology Co.,...

Recruiting

Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder

Insomnia Disorder

China
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...

Not yet recruiting

A Phase 2 Clinical Study of Evaluation of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) Combined With Doxorubicin Hydrochloride in the Treatment of Metastatic/Unresectable Non-specific Soft Tissue Sarcoma

Sarcoma, Soft Tissue

China
Shanghai Shenqi Medical Technology Co., Ltd

Recruiting

SQ-Kyrin TMVr FIM Study

Mitral Regurgitation

China
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...

Recruiting

601 Versus Ranibizumab in Patients With Pathological Myopic Choroidal Neovascularization (pmCNV)

Pathological Myopic Choroidal Neovascularization

China
UBP Greater China (Shanghai) Co., Ltd

Not yet recruiting

UB-621, a New Type of Anti-herpes Simplex Virus (HSV) Monoclonal Antibody for the Use in the Treatment of Adult Recurrent HSV-2 Infections of the Genitals

Recurrent Genital Herpes
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...

Recruiting

Efficacy and Safety Study of Combination of CPGJ602 and Chemotherapy, in First Line, With Wild KRAS/NRAS/BRAF in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
UBP Greater China (Shanghai) Co., Ltd

Not yet recruiting

The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients (HIV-1)

HIV-1-infection
UBP Greater China (Shanghai) Co., Ltd

Not yet recruiting

Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of UB-221 in Healthy Volunteers

Chronic Spontaneous Urticaria
Shanghai MicroPort Medical (Group) Co., Ltd.

Not yet recruiting

Trial for MicroPort's Firesorb BVS: FUTURE-III (FUTURE-III)

Coronary Artery Disease

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Recruiting

Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery Disease

Coronary Disease | Percutaneous Coronary Intervention | Dual Antiplatelet Therapy | Drug Eluting Stent

China
MacroGenics
Zai Lab (Shanghai) Co., Ltd.

Active, not recruiting

Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer (MAHOGANY)

Gastric Cancer | Gastroesophageal Junction Cancer | HER2-positive Gastric Cancer

Korea, Republic of, United States, China, Italy, Taiwan, Germany, Singapore, United Kingdom, Poland
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

A Trial of Firesorb in Patients With Coronary Artery Disease: FUTURE-II (FUTURE-II)

Coronary Artery Disease

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

Using Left Atrium Appendage Closure in NVAF Patients With High Risk of Ischemic Stroke (SAFE-PROTECT)

Stroke | Atrial Fibrillation

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

Evaluation of New Specifications (2.25mm) of FirehawkTM in the Treatment of Coronary Heart Disease ( Firehawk_2.25 )

Coronary Heart Disease

China
Shanghai Belief-Delivery BioMed Co., Ltd

Active, not recruiting

Evaluation of the Safety and Efficacy of Hemophilia B Gene Therapy Drug

Hemophilia B

China
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.

Suspended

A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease (GREEN MEMORY)

Alzheimer Disease

Hong Kong, China, United States, Canada, Poland, France, Australia, Czechia, Netherlands, Taiwan
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...

Completed

Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers

Healthy

United States
Shanghai Hongyitang Biopharmaceutical Technology...

Completed

A Phase IIa Clinical Trial on TSG-01 in the Treatment of Chronic Heart Failure in Patients With Coronary Heart Disease.

Chronic Heart Failure

China
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...

Unknown

601 Versus Ranibizumab in Patients With Branch Retinal Vein Occlusion (BRVO)

Branch Retinal Vein Occlusion

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Unknown

Safety and Efficacy of Rotator Cuff Function Restoration Balloon in Irreparable Rotator Cuff Tear

Rotator Cuff Tears
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...

Completed

Safety and Efficacy Study of Prefilled Liquid Etanercept(Yisaipu) for Active Ankylosing Spondylitis

Ankylosing Spondylitis

China
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...

Unknown

Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A

Solid Tumors

United States
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

Firehawk™ Coronary Stent System in the Treatment of Coronary Chronic Total Occlusion Lesion(s)

Percutaneous Coronary Intervention | Drug-Eluting Stents | Tomography, Optical Coherence

China
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...

Unknown

The Study of Drug 601 in Patients With Diabetic Macular Edema (DME)

Diabetic Macular Edema

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

The First-In-Man Pilot Study of Firehawk

Coronary Heart Disease
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

Observational Registry Study: FIREHAWK DES for Treating Coronary Artery Disease (CAD)

Coronary Artery Disease

China
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...

Unknown

Pharmacokinetics, Efficacy and Safety of the 304 Injection

CD20 Positive B Cell NHL

China
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...

Unknown

A Study of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
Shanghai GeneChem Co., Ltd.
RenJi Hospital

Unknown

A Study of CD19 Redirected Autologous T Cells for CD19 Positive Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus (SLE)

China
Shanghai Celgen Bio-Pharmaceutical Co.,Ltd

Unknown

Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis

Psoriasis | Plaque Psoriasis

China
Shanghai Golden Leaf MedTec Co. Ltd

Unknown

Renal Denervation for the Treatment of Hypertension: A Pilot Safety and Efficacy Study

Hypertension

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Unknown

Firebird2 Cobalt-Chromium Alloyed Sirolimus-Eluting Stent Registry Trial (FOCUS)

Coronary Heart Disease

China
Shanghai CP Guojian Pharmaceutical Co., Ltd.

Completed

Study for HER2-Overexpressed MBC Patients Treated by Cipterbin® Plus vinorelbinE (HOPES)

Adverse Events | Progress-free Survival | Overall Response Rate
Shanghai MicroPort EP MedTech Co., Ltd.

Recruiting

A Dual Energy Catheter (PFA and RFA) and a PFA Catheter for the Treatment of PeAF (PFA，RFA，PeAF)

Persistent Atrial Fibrillation

China
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...

Not yet recruiting

A Study to Evaluate 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)

Axial Spondyloarthritis

China
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...

Recruiting

Evaluation of 611(Recombinant Humanized Anti-interleukin-4 Receptor Alpha IgG4 Monoclonal Antibody) in Chinese Adults With Moderate to Severe Atopic Dermatitis

Dermatitis, Atopic

China
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...

Not yet recruiting

A Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute Gout

Acute Gout
Shanghai Runshi Pharmaceutical Technology Co., Ltd

Not yet recruiting

Relative Bioavailability and Food Effect of SYHA1813 Oral Solution in Healthy Participants

Healthy Participants
Shanghai Ming Ju Biotechnology Co., Ltd.

Recruiting

A Phase 1, Single-arm, Open-label, Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma

Liver Carcinoma | Hepatic Cell Carcinoma

China

Clinical Trials Sponsored by Shanghai Jiatan Pharmatech Co., Ltd

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations